Robert I. Tepper, co-founder of Third Rock Ventures, focuses on the formation, development and scientific strategy of Third Rock’s portfolio companies as well as actively identifies and evaluates new investments. Dr. Tepper also assumes active leadership roles in Third Rock’s portfolio companies, functioning as chief scientific officer through the first 12–18 months post launch.
Prior to joining Third Rock, Tepper was president of research and development at Millennium Pharmaceuticals and was vital in its expansion from a drug discovery company to a fully integrated biopharmaceutical company. Prior to joining Millennium, Tepper co-founded Cell Genesys/Abgenix.
Currently, Tepper serves as an adjunct faculty member at Harvard Medical School and Massachusetts General Hospital and is an advisory board member of several leading health care institutions, including the Partners HealthCare Center for Personalized Genetic Medicine, Harvard Medical School and Tufts Medical School.
Tepper earned his medical degree from Harvard Medical School.